We recently characterized a large developmentally regulated gene family in Leishmania encoding the amastin surface proteins. While studying the regulation of these genes, we identified a region of 770 nucleotides (nt) within the 2055-nt 3-untranslated region (3-UTR) that regulates stage-specific gene expression at the level of translation. An intriguing feature of this 3-UTR regulatory region is the presence of a ϳ450-nt element that is highly conserved among several Leishmania mRNAs. Here we show, using a luciferase reporter system and polysome profiling experiments, that the 450-nt element stimulates translation initiation of the amastin mRNA in response to heat shock, which is the main environmental change that the parasite encounters upon its entry into the mammalian host. Deletional analyses depicted a second region of ϳ100 nucleotides located at the 3-end of several amastin transcripts, which also activates translation in response to elevated temperature. Both 3-UTR regulatory elements act in an additive manner to stimulate amastin mRNA translation. In addition, we show that acidic pH encountered in the phagolysosomes of macrophages, the location of parasitic differentiation, triggers the accumulation of amastin transcripts by a distinct mechanism that is independent of the 450-nt and 100-nt elements. Overall, these important findings support the notion that stage-specific post-transcriptional regulation of the amastin mRNAs in Leishmania is complex and involves the coordination of distinct mechanisms controlling mRNA stability and translation that are independently triggered by key environmental signals inducing differentiation of the parasite within macrophages.The protozoan parasite Leishmania constitutes a major health problem in several endemic tropical and sub-tropical regions around the world, threatening over 350 million people of which more than 15 million are infected (1, 2). At least 20 different Leishmania species are responsible for the various clinical manifestations of leishmaniasis, ranging from chronic skin ulcers (L. major, L. tropica, and L. mexicana) to more severe naso-pharynx mucosal destruction (L. braziliensis) or life-threatening visceral diseases (L. donovani, L. infantum, and L. chagasi) (3). No effective vaccine is currently available against Leishmania infections, and resistance to the main anti-leishmanial agents is dramatically increasing in several endemic areas (4). These facts have underscored the urgency of identification of new drug targets for chemotherapy and/or vaccine development.The life cycle of Leishmania includes two developmental stages: the extracellular promastigote form, transmitted to the mammalian host by the sand fly vector, and the amastigote form, adapted to resist and replicate within the threatening environment of the phagolysosomes. This adaptation requires a dynamic process implicating morphological and physiological changes within the parasite (5-9) that are mainly orchestrated by the differential expression of a variety of genes. To date, sever...